X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bone5 (22) 22
humans (22) 22
index medicus (22) 22
oncology (22) 22
original reports (19) 19
middle aged (15) 15
female (14) 14
adult (13) 13
male (13) 13
aged (12) 12
bone2 (12) 12
bone1 (11) 11
hematopoietic stem cell transplantation (6) 6
hematopoietic stem cell transplantation - adverse effects (6) 6
multiple myeloma - drug therapy (6) 6
survival rate (6) 6
transplantation, homologous (6) 6
treatment outcome (6) 6
adolescent (5) 5
bone-marrow-transplantation (5) 5
psc12 (5) 5
retrospective studies (5) 5
stem-cell transplantation (5) 5
survival (5) 5
transplantation, autologous (5) 5
young adult (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
child (4) 4
child, preschool (4) 4
dexamethasone (4) 4
disease (4) 4
follow-up studies (4) 4
hematologic neoplasms - therapy (4) 4
prognosis (4) 4
survivors (4) 4
therapy (4) 4
age factors (3) 3
aged, 80 and over (3) 3
bone4 (3) 3
bortezomib (3) 3
cancer (3) 3
chemotherapy (3) 3
cmpl4 (3) 3
cohort studies (3) 3
combined modality therapy (3) 3
disease-free survival (3) 3
hema21 (3) 3
hematologic neoplasms - mortality (3) 3
kaplan-meier estimate (3) 3
melphalan - therapeutic use (3) 3
multiple myeloma - mortality (3) 3
multiple myeloma - therapy (3) 3
neoplasm staging (3) 3
psc13 (3) 3
thalidomide (3) 3
time factors (3) 3
autologous transplantation (2) 2
bone3 (2) 2
cancer survivors (2) 2
chromosome aberrations (2) 2
classification (2) 2
comorbidity (2) 2
cyclophosphamide - administration & dosage (2) 2
disease progression (2) 2
double-blind (2) 2
drug administration schedule (2) 2
functional status (2) 2
graft vs host disease - etiology (2) 2
health behaviors (2) 2
hema19 (2) 2
hema22 (2) 2
infant (2) 2
leukemia, myeloid, acute - surgery (2) 2
life style (2) 2
long-term survivors (2) 2
lymphoma (2) 2
maintenance (2) 2
melphalan (2) 2
mortality (2) 2
multiple myeloma - genetics (2) 2
multiple myeloma - pathology (2) 2
multiple-myeloma (2) 2
multivariate analysis (2) 2
neoplasm recurrence, local - diagnosis (2) 2
neoplasm recurrence, local - drug therapy (2) 2
neoplasm recurrence, local - mortality (2) 2
neoplasms - mortality (2) 2
neoplasms - surgery (2) 2
neoplasms - therapy (2) 2
outcomes (2) 2
pedi17 (2) 2
polymorphism, single nucleotide (2) 2
positron-emission tomography (2) 2
precursor cell lymphoblastic leukemia-lymphoma - surgery (2) 2
prednisone (2) 2
psc5 (2) 2
quality of life (2) 2
randomized-trial (2) 2
recurrence (2) 2
relapse (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 09/2009, Volume 27, Issue 27, pp. 4585 - 4590
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2013, Volume 31, Issue 18, pp. 2347 - 2357
Purpose The aim of the International Myeloma Working Group was to develop practice recommendations for the management of multiple myeloma (MM) -related bone... 
ZOLEDRONIC ACID | ONCOLOGY | VERTEBRAL AUGMENTATION | SKELETAL-RELATED EVENTS | DOUBLE-BLIND | UNDETERMINED SIGNIFICANCE | RANDOMIZED-TRIAL | MONOCLONAL GAMMOPATHY | SPINAL-CORD COMPRESSION | VITAMIN-D DEFICIENCY | PERCUTANEOUS VERTEBROPLASTY | Outcome Assessment (Health Care) - methods | Humans | Imidazoles - administration & dosage | Tomography, X-Ray Computed | Positron-Emission Tomography | Fractures, Bone - diagnosis | Medical Oncology - organization & administration | Multiple Myeloma - drug therapy | Bone Diseases - drug therapy | Diphosphonates - therapeutic use | Imidazoles - therapeutic use | Drug Therapy, Combination | Osteonecrosis - diagnosis | Bone Diseases - complications | Multiple Myeloma - complications | Bone Density Conservation Agents - therapeutic use | Bone Diseases - radiotherapy | Combined Modality Therapy | Diphosphonates - administration & dosage | International Cooperation | Bone Density Conservation Agents - administration & dosage | Magnetic Resonance Imaging | Administration, Intravenous | Radiotherapy - methods | Clodronic Acid - therapeutic use | Clodronic Acid - administration & dosage | Multiple Myeloma - radiotherapy | Osteonecrosis - prevention & control | Fractures, Bone - prevention & control | Practice Guidelines as Topic | Index Medicus | Hema20 | Gdln2 | Bone5 | Special | Hema23 | Hema22 | Hema21
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2015, Volume 33, Issue 32, pp. 3741 - 3749
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2013, Volume 31, Issue 19, pp. 2437 - 2449
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2013, Volume 31, Issue 12, pp. 1530 - 1538
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2012, Volume 30, Issue 30, pp. 3746 - 3751
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2013, Volume 31, Issue 16, pp. 1984 - 1989
Purpose Despite improved outcomes for multiple myeloma, little is known about changes in initial treatment at the population level for US patients. We report... 
SURVIVAL | TRIAL | STANDARD CHEMOTHERAPY | PREDNISONE | DEXAMETHASONE | ONCOLOGY | HIGH-DOSE THERAPY | PLUS THALIDOMIDE | STEM-CELL TRANSPLANTATION | ELDERLY-PATIENTS | MELPHALAN | Practice Patterns, Physicians' - economics | Asian Americans - statistics & numerical data | Multiple Myeloma - economics | United States | Humans | Middle Aged | Hispanic Americans - statistics & numerical data | Male | Transplantation, Autologous | Antineoplastic Agents - therapeutic use | Hematopoietic Stem Cell Transplantation - economics | Insurance, Health - statistics & numerical data | Multiple Myeloma - drug therapy | Multiple Myeloma - therapy | Molecular Targeted Therapy - trends | Vincristine - administration & dosage | Adult | Female | Retrospective Studies | Medicaid | Multiple Myeloma - surgery | Doxorubicin - administration & dosage | SEER Program | Medicare | Molecular Targeted Therapy - utilization | European Continental Ancestry Group - statistics & numerical data | Logistic Models | Treatment Outcome | Molecular Targeted Therapy - economics | Antineoplastic Agents - economics | Practice Patterns, Physicians' - trends | African Americans - statistics & numerical data | Melphalan - administration & dosage | Confounding Factors (Epidemiology) | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | ORIGINAL REPORTS | Hema22 | Bone5 | Hema21
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2015, Volume 33, Issue 12, pp. 1364 - 1370
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2010, Volume 28, Issue 23, pp. 3754 - 3761
Journal Article